CD83 influences cell-surface MHC class II expression on B cells and other antigen-presenting cells

International Immunology

Volumn 19, Issue 8, 2007, Pages 977-992

  Kuwano, Yoshihiro ^a,b   Prazma, Charlene M ^c   Yazawa, Norihito ^a,c   Watanabe, Rei ^a,b   Ishiura, Nobuko ^a,b   Kumanogoh, Atsushi ^d   Okochi, Hitoshi ^b   Tamaki, Kunihiko ^a   Fujimoto, Manabu ^a,b,e   Tedder, Thomas F ^c  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d OSAKA UNIVERSITY   (Japan)

^e KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

B cell; CD83; Cell surface expression; MHC class II; Turnover

Indexed keywords

CD83 ANTIGEN; HETERODIMER; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMBRANE ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHEMICAL STRUCTURE; DENDRITIC CELL; EPITHELIUM CELL; IMMUNOREGULATION; INTERNALIZATION; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PHENOTYPE; PRIORITY JOURNAL; THYMUS;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; B-LYMPHOCYTES; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOGLOBULINS; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, MUTANT STRAINS; T-LYMPHOCYTES;

EID: 34548563892     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm067     Document Type: Article

References (70)

1. Zhou, L. -J., Schwarting, R., Smith, H. M. and Tedder, T. F. 1992. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells and activated lymphocytes is a new member of the immunoglobulin superfamily. J. Immunol. 149:735.
2. Zhou, L. -J. and Tedder, T. F. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154:3821.
3. Twist, C. J., Beier, D. R., Disteche, M. C., Edelhoff, S. and Tedder, T. F. 1998. The mouse CD83 antigen: Structure, domain organization and chromosome localization. Immunogenetics 48:383.
4. Kozlow, E. J., Wilson, G. L., Fox, C. H. and Kehrl, J. H. 1993. Subtractive cDNA cloning of a novel member of the Ig gene superfamily expressed at high levels in activated B lymphocytes. Blood 81:454.
5. Weissman, D., Li, Y., Ananworanich, J. et al. 1995. Three populations of cells with dendritic morphology exist in peripheral blood, only one of which is infectable with human immunodeficiency virus type 1. Proc. Natl Acad. Sci USA. 92:826.
6. + dendritic cells. Proc. Natl Acad. Sci. USA. 93:2588.
7. Wolenski, M., Cramer, S. O., Ehrlich, S. et al. 2003. Expression of CD83 in the murine immune system. Med. Microbiol. Immunol. 192:189.
8. McKinsey, T., Chu, Z. -L., Tedder, T. F. and Ballard, D. W. 2000. Transcription factor NF-κB regulates inducible CD83 gene expression in activated T lymphocytes. Mol. Immunol. 37:783.
9. Kruse, M., Rosorius, O., Kratzer, F. et al. 2000. Inhibition of CD83 cell surface expression during dendritic cell maturation by interference with nuclear export of CD83 mRNA. J. Exp. Med. 191:1581.
10. Dudziak, D., Kieser, A., Dirmeier, U. et al. 2003. Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-κB signaling pathway. J. Virol. 77:8290.
11. Prechtel, A. T., Chemnitz, J., Schirmer, S. et al. 2006. Expression of CD83 is regulated by HuR via a novel cis-active coding region RNA element. J. Biol. Chem. 281:10912.
12. + T cell development in the thymus. Cell. 108:755.
13. + T cells. J. Immunol. 173:2995.
14. + T cells. J. Immunol. 166:3865.
15. Scholler, N., Hayden-Ledbetter, M., Dahlin, A., Hellstrom, I., Hellstrom, K. E. and Ledbetter, J. A. 2002. Cutting edge: CD83 regulates the development of cellular immunity. J. Immunol. 168:2599.
16. Lechmann, M., Krooshoop, D. J. E.B., Dudziak, D. et al. 2001. The extracellular domain of CD83 inhibits dendritic cell-mediated Tcell stimulation and binds to a ligand on dendritic cells. J. Exp. Med. 194:1813.
17. Lechmann, M., Kremmer, E., Sticht, H. and Steinkasserer, A. 2002. Overexpression, purification, and biochemical characterization of the extracellular human CD83 domain and generation of monoclonal antibodies. Protein Expr. Purif. 24:445.
18. Lechmann, M., Kotzor, N., Zinser, E., Prechtel, A. T., Sticht, H. and Steinkasserer, A. 2005. CD83 is a dimer: Comparative analysis of monomeric and dimeric isoforms. Biochem. Biophys. Res. Commun. 329:132.
19. Kotzor, N., Lechmann, M., Zinser, E. and Steinkasserer, A. 2004. The soluble form of CD83 dramatically changes the cytoskeleton of dendritic cells. Immunobiology. 209:129.
20. Dudziak, D., Nimmerjahn, F., Bornkamm, G. W. and Laux, G. 2005. Alternative splicing generates putative soluble CD83 proteins that inhibit T cell proliferation. J. Immunol. 174:6672.
21. Zinser, E., Lechmann, M., Golka, A., Lutz, M. B. and Steinkasserer, A. 2004. Prevention and treatment of experimental autoimmune encephalomyelitis by soluble CD83. J. Exp. Med. 200:345.
22. Cramer, S. O., Trumpfheller, C., Mehlhoop, U., Moré, S., Fleischer, B. and von Bonin, A. 2000. Activation-induced expression of murine CD83 on T cells and identification of a specific CD83 ligand on murine B cells. Int. Immunol. 12:1347.
23. + T cells and preferential enrichment for antigen specificity. Blood 107:1528.
24. Ohta, Y., Landis, E., Boulay, T. et al. 2004. Homologs of CD83 from elasmobranch and teleost fish. J. Immunol. 173:4553.
25. + cytolytic T cells. Nature 344:742.
26. + T cells. Science 248:1227.
27. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417.
28. Cosgrove, D., Gray, D., Dierich, A. et al. 1991. Mice lacking MHC class II molecules. Cell.. 66:1051.
29. Fung-Leung, W. P., Surh, C. D., Liljedahl, M. et al. 1996. Antigen presentation and T cell development in H2-M-deficient mice. Science 271:1278.
30. + T cell selection in mice lacking invariant chain expression. J. Exp. Med. 177:1699.
31. Miyazaki, T., Wolf, P., Tourne, S. et al. 1996. Mice lacking H2-M complexes, enigmatic elements of the MHC class II peptide-loading pathway. Cell. 84:531.
32. + T cell selection independently of its effect on invariant chain: A role in the generation of positively selecting peptide ligands. J. Exp. Med. 195:1349.
33. Klein, E., Koch, S., Borm, B. et al. 2005. CD83 localization in a recycling compartment of immature human monocyte-derived dendritic cells. Int. Immunol. 17:477.
34. Anderson, G., Jenkinson, E. J., Moore, N. C. and Owen, J. J. 1993. MHC class II-positive epithelium and mesenchyme cells are both required for T-cell development in the thymus. Nature 362:70.
35. Robinson, J. H. and Owen, J. J. 1977. Generation of T-cell function in organ culture of foetal mouse thymus. II. Mixed lymphocyte culture reactivity. Clin. Exp. Immunol. 27:322.
36. Fujimoto, M., Bradney, A. P., Poe, J. C., Steeber, D. A. and Tedder, T. F. 1999. Modulation of B lymphocyte antigen receptor signal transduction by a CD19/CD22 regulatory loop. Immunity 11:191.
37. Arai, C., Ichijo, T., Tanaka, Y. et al. 2003. Selective enhancement of B cell antigen receptor-mediated antigen presentation by treatment with transforming growth factor-β. Eur. J. Immunol. 33:1806.
38. Germain, R. N. and Hendrix, L. R. 1991. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding. Nature 353:134.
39. Cella, M., Engering, A., Pinet, V., Pieters, J. and Lanzavecchia, A. 1997. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature. 388:782.
40. Ma, Q., Renzelli, A. J., Baldwin, K. T. and Antonini, J. M. 2000. Superinduction of CYP1A1 gene expression. Regulation of 2,3,7, 8-tetrachlorodibenzo-p-dioxin-induced degradation of Ah receptor by cycloheximide. J. Biol. Chem. 275:12676.
41. Rahmsdorf, H. J., Harth, N., Eades, A. M. et al. 1986. Interferongamma, mitomycin C, and cycloheximide as regulatory agents of MHC class II-associated invariant chain expression. J. Immunol. 136:2293.
42. Wilson, N. S., El-Sukkari, D. and Villadangos, J. A. 2004. Dendritic cells constitutively present self antigens in their immature state in vivo and regulate antigen presentation by controlling the rates of MHC class II synthesis and endocytosis. Blood 103:2187.
43. Ohmura-Hoshino, M., Matsuki, Y., Aoki, M. et al. 2006. Inhibition of MHC class II expression and immune responses by c-MIR. J. Immunol. 177:341.
44. Shin, J. S., Ebersold, M., Pypaert, M., Delamarre, L., Hartley, A. and Mellman, I. 2006. Surface expression of MHC class II in dendritic cells is controlled by regulated ubiquitination. Nature 444:115.
45. van Niel, G., Wubbolts, R., Ten Broeke, T. et al. 2006. Dendritic cells regulate exposure of MHC class II at their plasma membrane by oligoubiquitination. Immunity 25:885.
46. Sadegh-Nasseri, S. and Germain, R. N. 1991. A role for peptide in determining MHC class II structure. Nature 353:167.
47. Thery, C., Brachet, V., Regnault, A. et al. 1998. MHC class II transport from lysosomal compartments to the cell surface is determined by stable peptide binding, but not by the cytosolic domains of the α and β chains. J. Immunol. 161:2106.
48. Bhattacharya, A., Dorf, M. E. and Springer, T. A. 1981. A shared alloantigenic determinant on Ia antigens encoded by the I-A and IE subregions: Evidence for I region gene duplication. J. Immunol. 127:2488.
49. Janeway, C. A. Jr., Conrad, P. J., Lerner, E. A., Babich, J., Wettstein, P. and Murphy, D. B. 1984. Monoclonal antibodies specific for Ia glycoproteins raised by immunization with activated T cells: Possible role of T cell bound Ia antigens as targets of immunoregulatory T cells. J. Immunol. 132:662.
50. Liljedahl, M., Winqvist, O., Surh, C. D. et al. 1998. Altered antigen presentation in mice lacking H2-O. Immunity 8:233.
51. Wong, P., Barton, G. M., Forbush, K. A. and Rudensky, A. Y. 2001. Dynamic tuning of T cell reactivity by self-peptide-major histocompatibility complex ligands. J. Exp. Med. 193:1179.
52. Denzin, L. K. and Cresswell, P. 1995. HLA-DM induces CLIP dissociation from MHC class II αβ dimers and facilitates peptide loading. Cell. 82:155.
53. Martin, W. D., Hicks, G. G., Mendiratta, S. K., Leva, H. I., Ruley, H. E. and Van Kaer, L. 1996. H2-M mutant mice are defective in the peptide loading of class II molecules, antigen presentation, and T cell repertoire selection. Cell. 84:543.
54. Kenty, G., Martin, W. D., Van Kaer, L. and Bikoff, E. K. 1998. MHC class II expression in double mutant mice lacking invariant chain and DM functions. J. Immunol. 160:606.
55. Viville, S., Neefjes, J., Lotteau, V. et al. 1993. Mice lacking the MHC class II-associated invariant chain. Cell. 72:635.
56. Vacchio, M. S., Lee, J. Y. and Ashwell, J. D. 1999. Thymus-derived glucocorticoids set the thresholds for thymocyte selection by inhibiting TCR-mediated thymocyte activation. J. Immunol. 163:1327.
57. Yasutomo, K., Lucas, B. and Germain, R. N. 2000. TCR signaling for initiation and completion of thymocyte positive selection has distinct requirements for ligand quality and presenting cell type. J. Immunol. 165:3015.
58. Hare, K. J., Jenkinson, E. J. and Anderson, G. 1999. CD69 expression discriminates MHC-dependent and -independent stages of thymocyte positive selection. J. Immunol. 162:3978.
59. Eck, S. C., Zhu, P., Pepper, M., Bensinger, S. J., Freedman, B. D. and Laufer, T. M. 2006. Developmental alterations in thymocyte sensitivity are actively regulated by MHC class II expression in the thymic medulla. J. Immunol. 176:2229.
60. Azzam, H. S., Grinberg, A., Lui, K., Shen, H., Shores, E. W. and Love, P. E. 1998. CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity. J. Exp. Med. 188:2301.
61. Anderson, G., Hare, K. J. and Jenkinson, E. J. 1999. Positive selection of thymocytes: The long and winding road. Immunol. Today 20:463.
62. Anderson, G., Hare, K. J., Platt, N. and Jenkinson, E. J. 1997. Discrimination between maintenance- and differentiation-inducing signals during initial and intermediate stages of positive selection. Eur. J. Immunol. 27:1838.
63. Madsen, L., Labrecque, N., Engberg, J. et al. 1999. Mice lacking all conventional MHC class II genes. Proc. Natl Acad. Sci USA 96:10338.
64. Boniface, J. J., Rabinowitz, J. D., Wulfing, C. et al. 1998. Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands. Immunity 9:459.
65. Cochran, J. R., Cameron, T. O. and Stern, L. J. 2000. The relationship of MHC-peptide binding and T cell activation probed using chemically defined MHC class II oligomers. Immunity 12:241.
66. Breloer, M., Kretschmer, B., Luthje, K. et al. 2007. CD83 is a regulator of murine B cell function in vivo. Eur. J. Immunol. 37:634.
67. Boes, M., Cerny, J., Massol, R. et al. 2002. T-cell engagement of dendritic cells rapidly rearranges MHC class II transport. Nature 418:983.
68. Chow, A., Toomre, D., Garrett, W. and Mellman, I. 2002. Dendritic cell maturation triggers retrograde MHC class II transport from lysosomes to the plasma membrane. Nature 418:988.
69. Cao, W., Lee, S. H. and Lu, J. 2005. CD83 is preformed inside monocytes, macrophages and dendritic cells, but it is only stably expressed on activated dendritic cells. Biochem. J. 385:85.
70. Goto, E., Ishido, S., Sato, Y. et al. 2003. c-MIR, a human E3 ubiquitin ligase, is a functional homolog of herpesvirus proteins MIR1 and MIR2 and has similar activity. J. Biol. Chem. 278:14657.